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Abstract. In Xenopus oocytes, the mos proto-
oncogene product is required during meiosis I for the
activation of maturation promoting factor (MPF) and
the subsequent breakdown of the germinal vesicle
(GVBD) . In addition, the mos product has been shown
to be a candidate "initiator" of meiotic maturation and
is an active component of cytostatic factor (CSF), an
activity responsible for metaphase II arrest. Here we
demonstrate that pp39mos is required throughout oocyte
maturation . We found that in progesterone stimulated
oocytes, depletion of mos RNA immediately before
GVBD terminally decreased MPF. Likewise, oocytes
depleted of mos RNA and induced to mature with
crude MPF proceeded through GVBD, but lacked the
F
UI.I.Y grown Xenopus oocytes arrested in prophase of
meiosis I (Masui and Clarke, 1979) are induced to
mature with progesterone, resulting in the activation
of maturation promoting factor (MPF)' and the progression
through meiosis (Masui and Markert, 1971; Ford, 1985).
MPF is a cytoplasmic protein kinase activity that leads to nu-
clear envelope breakdown as well as chromosome condensa-
tion (Miake-Lye et al., 1983; Maller, 1985) and consists of
two proteins, the homologue of the p34c&z protein from
Schizosaccharomyces pombe (Gautier et al ., 1988; Dunphy
et al., 1988) and a cyclin protein (Draetta et al., 1989 ;
Meijer et al ., 1989; Pines and Hunter, 1989; Gautier et al.,
1990) . Progesterone treatment of Xenopus oocytes rapidly
induces the synthesis of the mos proto-oncogene product,
pp39m°s, that precedes MPF activation and germinal vesicle
breakdown (GVBD) (Sagata et al ., 19ß9a). Moreover, the
introduction of c-mosxe RNA into fully grown oocytes trig-
gers the activation of MPF and GVBD (Sagata et al., 19ß9a ;
Freeman et al., 1989).
In Xenopus oocytes, pp39mo, is required for MPF activa-
tion and GVBD induced by progesterone (Sagata et al.,
1988 ; Barrett et al., 1990), while in mouse oocytes,
R. S. Paules' present addressis MammalianMolecular Genetics Group, Na-
tional Institute ofEnvironmental Health Sciences, Research Triangle Park,
NC 27709.
1. Abbreviations used in thispaper: CSF, cytostatic factor; GVBD, germinal
vesicle breakdown; MPF, maturation promoting factor.
0 The Rockefeller University Press, 0021-9525/91/07/329/7 $2.00
The Journal of Cell Biology, Volume 114, Number 2, July 1991 329-335
MPF activity required to arrest mature oocytes at
metaphase II . Thus, during maturation the mos prod-
uct is required, directly or indirectly, to sustain MPF
activity. On the other hand, mouse NIH/3T3 cells
transformed by the constitutive expression of pp39mo,-
possessed CSF activity but lacked constitutive levels
of MPF or its associated histone HI kinase activity.
Moreover, cytosols prepared from transformed NIH/
3T3 cells or Xenopus eggs had similar levels of CSF
activity, but pp39mo5 levels were >40-fold higher in the
transformed cell extract. These analyses show that
maintenance of CSF during interphase does not result
in the maintenance of MPF.
pp39m,, is required only after GVBD (O'Keefe et al., 1989 ;
Paules et al., 1989). Moreover, the mos product is expressed
throughout maturation in both Xenopus and mouse oocytes
undergoing maturation (Sagata et al., 1988; Watanabe et al.,
1989; Paules et al., 1989). The above evidence suggests that
pp39m°s function is required throughout meiotic maturation
(Paules et al., 1989). Recently, pp39mos has been identified
as an active component of cytostatic factor (CSF) (Sagata et
al., 19ß9b), a calcium-sensitive activity believed to be
responsible for the arrest ofan unfertilized egg at metaphase
II and for the stabilization ofMPF (Masui and Clarke, 1979;
Newport and Kirschner, 1984; Sagata et al., 19ß9b ; Murray
et al., 1989) . Here we provide evidence that the mos product
is required throughout meiotic maturation for the main-
tenance of MPF In contrast, we show that CSF activity is
present in c-mos-transformed mouse NIH/3T3 cells dur-
ing interphase, while MPF activity is not.
Materials andMethods
Frogs, Oocytes, Eggs, and Embryos
Xenopus laevis females were purchased from Xenopus I (Ann Arbor, MI).
Oocytes were surgically removed and defolliculated by incubation in
modified Barth solution (MBS; 88 mM NaCl, 1 mM KCI, 2.4 mM
NaHC03, 10 mM Hepes [pH 7.5], 0.82 mM MgSO4, 0.33 mM Ca(N03)2,
0.41 mM CaCl2) containing collagenase A (Boehringer Mannheim Bio-
chemicals, Indianapolis, IN) (2 mg/ml) for 2 h (Gurdon and Wickens,
1983). The oocytes were washed in MBS several times before the stage VI
329(Dumont, 1972) oocytes were isolated. To obtain eggs, frogs were injected
with 100 IU ofpregnant mare serum gonadotropin 72 h before an injection
of625 IU ofhuman chorionic gonadropin into the dorsal lymph sac. Frogs
were maintained 12-14 h in lx MMR (0.1 M NaCl, 2 mM KCI, 1 mM
MgCl2, 2 mM CaC12, 0.1 mM EDTA, 5 mM Hepes [pH 7.8]) at 18°C,
and the laid eggs were transferred to a 100-mM dish containing 1 x MMR.
To obtain embryos, eggs were placed in 100% Ringers' solution (0.1 M
NaCl, 1.8 mM KCI, 1 MM MgCl2, 2 mM CaC12, 4 mM NaHC03).
Mincedtestes were added to the dish containing the eggs, and 2 vol of H2O
were added to dilute the Ringers' solution to 0.3 x . After 15 min, eggs were
dejellied in 0.3X MMR containing 2% cysteine (pH 7.9). The eggs were
washed several times with 0.3x MMR and cultured in 0.3 x MMR contain-
ing 5% Ficoll 400.
Oligodeoxyribonucleotide Injections
18 h after fully grown oocytes were isolated, microinjections were per-
formed with 40 nl of a mixture of either antisense or sense mos-specific
oligodeoxyribonucleotides (oligonucleotides; 3 mg/ml), denoted by At,
Bt, Ct, Dt as described by Sagata et al. (1988). Subsequent injections
of crude MPF were performed 4 h later.
MPFAssay
Crude MPF extracts were prepared by homogenizing groups of 10-20 oo-
cytes or embryos in 20-40 Al of extraction buffer (80 mM sodium 0-glyc-
erophosphate, 20 mM EGTA, 15 MM M9C12, 20 mM Hepes [pH 7.2],
1 mM ATP, 1 mM DTT, 5 mM NaF). The homogenate was centrifuged at
16,000g for 5 min at4°C, and the supernatant wasused formicroinjections.
Groups of 12-14 oocytes were incubated in Ix MBS containing cyclohexi-
mide (10 pg/ml) for 1 h and then injected with40 nl ofthe supernatant from
each appropriate donor group. The recipient oocytes were cultured 3-4 h
in the presence of cycloheximide, then examined for GVBD. GVBD was
scored by the observation of a white spot at the animal pole. The oocytes
were fixed in 10% TCA for 10 min, then dissected and examined under a
binocular microscope for the presence or absence of the germinal vesicle.
CSFAssay
Either eggs or NIH/3T3 cells expressing tpr-met, ras, orXenopusmos were
washed with CSF extraction buffer (0.25 M sucrose, 0.2 M NaCl, 5 mM
MgSO4, 2.5 mM EGTA, 20 mM Hepes [pH 6.5], 10 mM NaF, 80 mM so-
dium ß-glycerophosphate, 2 mM DTT, 6 mM ATP). The CSF extraction
buffer was removed, and the samples were crushed at 100,000 g at 2°C for
1.5 h. The supernatant was removed and 40 nl was injected into either one
or both blastomeres of a 2-cell embryo. The embryos were maintained in
0.3x MMR containing 5% Ficoll 400 for 4-6 h and examined for cleavage.
Histone HI Kinase Assay
2 At ofextractwastransferred into 50 At ofextractionbuffer (80 mM sodium
0-glycerophosphate, 20 mM EGTA, 50 MM M9C12, 20 mM Hepes [pH
7.2], 1 mM DTT, 2.5 mM PMSF, 10 pg/ml leupeptin, 10 Ag/ml aprotinin,
10 AM protein kinase inhibitor) . The histone Hl kinase reaction was per-
formed by adding 10 Alpfthe sample to 6 AI ofa mixture containing 1 pg/Al
histone Hl, 1 mM ATP, and 1 ACi [,y32P]ATP. The reaction was incubated
at roomtemperature for 15 min and then stopped by the addition ofan equal
volume of 2x sample buffer (4% SDS, 20% glycerol, 150 mM Tris-HCI
[pH 6.8], 0.02% bromophenol blue, 5% 0-mercaptoethanol). Samples were
resolved by SDS-PAGE on a 12% gel. Gels were fixed in 40% methanol,
5% acetic acid, then dried, and exposed to film.
Immunoprecipitation and Western BlottingAnalysis
From either 300 Xenopus eggs or 4 x 101 c-mos`°-transformed NIH/3T3
cells or nontransformed NIH/3T3 cells, a CSF extract was prepared as de-
scribedabove. To 100 WI ofeachextract, an equal amount of2x RIPAbuffer
plus protease inhibitors (2.0% NP-40, 1.0% sodium deoxycholate, 0.2%
SDS in PBS plus 5.0 mM PMSF and 120 kallikrein inhibitor units ofaproti-
nin per milliliter) was added. These samples were subjected to immunopre-
cipitation with the 5S monoclonal Xenopus mos antibody as described
(Sagata etal., 19ß9a). Immune complexes were resolved by 3-17% gradient
SDS-PAGE. Western transfer was performed as described (Burnette, 1981).
pp39m°' was detected with 5S monoclonal antibody and alkaline phos-
phatase-conjugated goat anti-mouse IgG.
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Immunoprecipitation and In Vitro KinaseAssay
To 100 A1 of CSF extract, 5S monoclonal antibody (Sagata et al., 19ß9a)
was added, incubated for 3 h, and complexed with 10% protein A-Seph-
arose in CSF buffer. The pellet was washed five times in wash buffer (1%
NP-40, 150 mM NaCl, 1 mM EDTA, 10 mM sodium phosphate, 20 AM
leupeptin, 2 mM PMSF, 10 AM pepstatin, 2 mM dithiothreitol, 120 kal-
likrein inhibitor units of aprotinin per milliliter). Then 50 AI of solution A
(0.1% NP-40,150 mM NaCl, 10 mM sodium phosphate [pH 7.2], 2 mM
DTT, 1 mM sodium pyrophosphate) and 5 Al of 2 mM quercitin (Sigma
Chemical Co., St. Louis, MO) was added to the immune complex and in-
cubated on ice for 10 min. After the addition of 50 At of solution B (0.1%
NP-40, 150 mM NaCl, 10 mM sodium phosphate [pH 7.2], 2 mM DTT,
1 mM sodium pyrophosphate, 15 mM MnC12, 20 AM ATP, 50 ACi of
[,y32P]ATP) the reaction mix was incubated at room temperature for 10
min. 2x sample buffer was added, and the sample was resolved on a 12%
SDS-polyacrylamide gel. Gels were fixed, dried, and exposed to film.
Cell Culture
NIH/3T3 cells transformed by the Xenopusmos product expressed from a
plasmid containing the Xenopus mos gene (Sagata et al., 1988) just down-
stream ofa Moloney sarcoma virus long terminal repeat (Yew et al., 1991)
were cultured in DMEM containing 8% calf serum. NIH/3T3 cells trans-
formed by either the activated H-ras oncogene (gift from Dr. Youyong Lu)
or the tpr-met oncogene (Park et al., 1986) were also cultured in DMEM
with 8 % calf serum. Mitotic cell cycle arrest was achieved by the addition
of medium containing 0.4 mg/ml of nocodozole (Calbiochem-Behring
Corp., Palo Alto, CA) and incubating the cell culture7.5-20h at 37°C. Mi-
totic cells were collected by shaking off the loosely attached cells and cen-
trifugation at 1,500 g for 5 min. The mitotic index was determined to be
-80% by light microscopy.
Results
Antisense Oligonucleotides Inhibit MPFActivation
after GVBD
The induction of MPF and GVBD by progesterone or insulin
is blocked by the injection of mos-specific antisense oligonu-
cleotides (Sagata et al., 1988) . To examine whether pp39m°'
synthesis is required after GVBD, fully grown stage VI oo-
cytes were microinjected with a mixture of either antisense
or sense mos-specific oligonucleotides and subsequently in-
jected with MPF to overcome the block to GVBD imposed
by the depletion of pp39m°s. Oocytes were cultured 8 h fol-
lowing GVBD to allow for progression through meiosis I and
arrest at metaphase II (Gerhart et al., 1984). Cytosolic ex-
Table L Lack ofMPFActivity after GVBD in Antisense
Oligonucleotide Injected Oocytes
Percent GVBD
Treatment
￿
Donor Recipient
* 8 h after GVBD, cytosolic extracts were prepared from oocytes that had
been injected with crude MPF extracts subsequent to either mos sense or an-
tisense oligonucleotide injection as described in Materials and Methods. These
donor extracts were injected into recipient cycloheximide-treated (10 /4g/ml)
oocytes and scored for GVBD as described in Materials and Methods.
t 8 h after GVBD, cytosolic extracts were prepared from oocytes that were
treated with progesterone and subsequently injected with either sense or an-
tisense mos oligonucleotides as described in Materials and Methods. These
donor extracts were injected into recipient cycloheximide-treated (10 hg/ml)
oocytes and scored for GVBD as described in Materials and Methods.
330
* Antisense oligonucleotide plus MPF 100 0
Sense oligonucleotide plus MPF 100 100
t Progesterone plus antisense oligonucleotide 100 0
Progesterone plus sense oligonucleotide 100 100C W
"- 41
l00-
> O
0
0
￿
80-
c
-0
m ia 04) 60-
ï,:o 40
4L
U . O
U
Time of Sense or Antisense Oligo Injection
1
1
1
1
1
1
1 1 1
1 1 1
1
i
1
0 "
0
￿
3.0 3.5 4.0 4.5 5.0
tracts were then prepared and tested for MPF activity by
microinjection into cycloheximide-treated fully grown oo-
cytes (Table I) . MPF can induce GVBD even in the presence
of cycloheximide (Wasserman and Masui, 1975 ; Cyert and
Kirschner, 1988) . Our experiments showed that mos RNA
depletion prevented the appearance ofMPF 8 h after GVBD
(Table I) . Moreover, there was a 50% increase in the time
required to reach GVBD in the mos RNA depleted oocytes
(data not shown) . These analyses demonstrated thatmos was
required afterGVBD, even in the presence of injected MPF,
and MPF-inducedGVBD was accelerated in the presence of
endogenous pp39m°, .
We tested whether pp39m°, synthesized before GVBD,
was sufficient to allow progression through later stages of
meiosis . Fully grown oocytes were treated with progesterone
(5 FtM) for 3 h, a time whereGVBD had occurred in -20%
of the oocytes, and a time when substantial mos protein syn-
thesis has occurred (Sagata et al., 1989a ; Watanabe et al.,
1989 ; data not shown) . Oocytes not displaying GVBD at
3 h were injected with either sense or antisense mos-specific
oligonucleotides . Under these conditions, GVBD was not
blocked bymos antisense oligonucleotides (Table I) . Oocytes
were cultured for an additional 8 h to allow progression to
metaphase II (Gerhart et al ., 1984) . When these oocytes
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Figure 1. Kinetics ofMPF and
histone Hl kinase activity in
the presence of sense or anti-
sense oligonucleotides . Stage
VI oocytes were treated with
progesterone . 4 h later, oocytes
were injected with 80 ng ofei-
ther sense or antisense mos oli-
gonucleotides . Cytosolic ex-
tracts were prepared from
groups ofsix oocytes at the in-
dicated times post-progesterone
6.5
￿
7.0
￿
7.5
￿
8.0
￿
addition, then assayed for his-
tone Hl kinase activity (A) or
MPF activity (B) .
were tested for MPF activity, none was found in the oocytes
depleted of mos RNA (Table I) . Collectively, these results
and previous findings (Sagata et al., 1988, 1989a, b ; Free-
man et al ., 1989 ; Barrett et al., 1990 ; Paules et al., 1989)
show that de novo synthesis of endogenous pp39mo5 is re-
quired afterGVBD for mouse or Xenopus oocyte maturation
and is required for the appearance and/or stabilization of
MPF at metaphase II .
The previous experiments showed that pp39m° , synthesis
was required afterGVBD for the maintenance ofMPR It was
formally possible that the maturing oocytes entered the sec-
ond meiosis with an accompanying rise inMPF, only to have
MPF levels fall as a function of time in the absence ofmos .
To determine whether the second rise in MPF occurred, oo-
cytes undergoing GVBD after 4 h of progesterone treatment
were injected with either sense or antisensemos oligonucleo-
tides and crude MPF extracts were prepared at half hour in-
tervals. These extracts were then tested for MPF activity and
histone Hl kinase activity (Fig . 1) . These analyses demon-
strate that MPF and histone Hl kinase activities terminally
decreasewithinthe first halfhour after mos antisense oligonu-
cleotides were injected (Fig . 1), while sense oligonucleotide
injected oocytes showed typical cycling ofMPF and histone
Hl kinase activity. These data show that pp39m°, synthesisFigure 2 . Kinetics of pp39mo5 proteolytic degradation after either
antisense oligonucleotide injection or cycloheximide treatment of
oocytes . Stage VI oocytes were continuously labeled during
progesterone treatment . After 3 h, oocytes were either injected with
antisense oligonucleotides or treated with cycloheximide (10 pg/
ml) . Atthe indicatedtimes, groups of 50 oocytes werehomogenized
in RIPA buffer and immunoprecipitation analysis was performed .
is required for the stabilization of MPF at metaphase I as
well as the induction ofMPF at metaphase II . To prove that
pp39m ,, was lost after antisense oligonucleotide treatment,
as suggested in previous studies with cycloheximide (Wata-
nabe et al., 1989), we continuously labeled oocytes for 3 h
in the presence of progesterone before microinjection with
antisense oligonucleotides or treatment of cycloheximide .
These analyses show that with either treatment the mos prod-
uct disappeared very rapidly (Fig . 2) .
Extractsfrom c-mos=e-transformed NIH/3T3 Cells
ContainCSF, butNotMPF
The mos product was required for MPF activity during
meiotic maturation in oocytes . In mouse cells transformed
by c-mos, ° (Freeman et al ., 1989 ; Yew et al ., 1991), mos is
expressed constitutively, and it has been proposed that this
may result in the stabilization of MPF during interphase
(Sagata et al ., 1989b) . We tested extracts prepared from
NIH/3T3 cells transformed by the Xenopus mos product for
CSF and MPF activity. Extracts microinjected into one
blastomere of a 2-cell embryo prevented cleavage as did con-
trol CSF extract prepared from Xenopus eggs, while the
uninjected blastomeres continued to cleave (Fig . 3) . In con-
trast, extracts prepared from nontransformed NIH/3T3 cells
or NIH/3T3 cells transformed by other oncogenes (i .e ., the
tyrosine kinase oncogene, tpr-met [Park et al ., 1986], or
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Figure 4 . (A) MPF and histone Hl kinase activity in extracts from
c-mosu-transformed cells . Extracts were prepared in CSF buffer
and tested for the ability to phosphorylate histone Hl in vitro as
described in Materials and Methods . The samples representing
Xenopus egg extracts (lane 1), a mixture of Xenopus egg and
c-mos,°-transformed cell extracts (lane 2), c-mosu-transformed
cell extract (lane 3), nontransformed NIH/3T3 cell extract (lane 4),
and immature Xenopus oocyte extract (lane S) were resolved by
SDS-PAGE . (B) Extracts from nocodazole arrested NIH/3T3 cells
(lane 1) and asynchronously growing NIH/3T3 cells (lane 2) were
prepared and tested for histone Hl kinase activity. 30 nl of the ex-
tracts described in A and B were microinjected into fully grown
oocytes maintained in MBS containing cycloheximide (10 ug/ml)
as described in Materials and Methods . The number ofoocytes that
underwent GVBD within 3-h postinjection are indicated above the
number of oocytes injected . These numbers are represented below
the corresponding lanes in A and B .
H-ras°el'z) were unable to induce cleavage arrest when in-
jected into embryos . Thus, extracts from somatic cells trans-
formed by the Xenopus mos proto-oncogene product spe-
cifically induced an embryonic cleavage arrest that was not
the result of an activity found in nontransformed NIH/3T3
cells or derivatives of these cells transformed by other on-
cogenes . CSF arrests embryonic cleavage at metaphase by
preventing directly or indirectly the inactivation of MPF
(Newport and Kirschner, 1984 ; Murray et al ., 1989 ; Sagata
et al., 1989b), and cleaving embryos arrested in metaphase
by extracts from c-more-transformed cells, like embryos ar-
rested by authentic egg CSF, were positive for MPF activity
(data not shown) .
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Figure 3 . CSF activity in mos ,°-transformed
cells and Xenopuseggs. Extracts were pre-
pared from Xenopus eggs and NIH/3T3
cells transformed by c-mosu, tpr-met, or
H-ras"a'z, and 30 nl was injected into 1 cell
of a 2-cell embryo as described in Materials
and Methods . The indicated dilutions were
made in CSF extraction buffer. Embryos
were scored for arrest in the 2- to 8-cell
stage . The number of arrested embryos per
number of embryos injected are indicated
above each histogram bar.Figure S. (A) Western blot analysis ofextracts prepared from Xeno-
pus eggs and c-mos--transformed cells. Immunoprecipitations and
Western blot analysis were performed on 100 141 ofextract prepared
from Xenopus eggs (lane 1), 17 pl from c-mos--transformed cells
(lane 2), 100,l from c-mos--transformed cells (lane 3), and 100
,ul from nontransformed NIH/3T3 cells (lane 4) as described in
Materials and Methods . (B) In vitro autophosphorylation of
pp39m°, from Xenopus eggs and c-mos--transformed cell extracts .
100 jil extracts from Xenopus eggs (lane 1), c-mos--transformed
cells (lane 2), and nontransformed NIH/3T3 cells (lane 3) were
prepared inCSF buffer, then subjected to immunoprecipitation, in
vitro autophosphorylation analysis, and Western transfer as de-
scribed in Materials and Methods . pp39mo5 and tubulin are de-
noted .
The previous experiments demonstrated thatCSF activity
was present in c-mos ,°-transformed NIH/3T3 cell extracts.
However, these same extracts were negative forMPF activity,
while extracts prepared from either Xenopus eggs or mitoti-
cally arrestedNIH/3T3 cells were positive forMPF (Fig . 4) .
We also tested the c-mos,°-transformed cell extracts for
MPF-associated histone Hl kinase activity (Fig . 4) and,
while extracts from eggs and mitotic NIH/3T3 cells displayed
high levels of this enzymatic activity, extracts from c-mos-
transformed cells were no higher in this activity than extracts
prepared from interphase nontransformed NIH/3T3 cells
(Fig . 4) . In addition, there was no evidence for the existence
of an MPF inhibitory factor in c-mosxe-transformed cell ex-
tracts, since mixtures of this extract with a Xenopus egg ex-
tract were positive for both MPF and histone Hl kinase ac-
tivity (Fig . 4) . Thus, CSF activity is present in interphase
Xenopusmos-transformed cells, butMPF does not appear to
be . We have not yet tested NIH/3T3 cells transformed with
other mos genes .
The LevelsofCSFActivityAre Similar inEggsand
mos,°-transformed Cells
The level ofCSF activity observed in extracts from c-mosxe_
transformed cells was similar to the level found in an equal
volume of extracts from unfertilized Xenopus eggs, i.e., the
egg extract had slightly more activity at a 1 :1 dilution (Fig.
War et al . OF in Xenopus Eggs and Transformed Cells
3) . The CSF activities were similar on a per unit volume ba-
sis even though the concentration of mos protein was 16
pg/ml in c-mos ,°-transformed cell extracts and 40 ng/ml in
egg extracts . We observed the same results when these ex-
tracts were diluted into cytosols prepared from either NIH/
3T3 cells or from fully grown oocytes that lackmos (data not
shown) . Thus, the difference in specific activity is not due
to transacting inhibitors in themouse cells or to an apparent
need for limiting factors present in the oocyte . Surprisingly,
Western analysis showed that there was at least 40 times
more pp39m in the extract prepared from the asynchronous
population of c-mos-transformed cells when compared to
an equal volume of egg extract (Fig . 5 A) . These results re-
vealed a dramatic variation in the ratio of CSF activity to
pp39m°, . The observed differences in specific activity were
apparently not due to M-phase, since extracts from cells
treated with nocodozole for 7-20 h displayed only slightly
moreCSF activity than Xenopus egg extracts at a 1 :3 dilution
(data not shown) .
A correlation has been established between in vitro auto-
phosphorylation activity and biological activity of the mos
proto-oncogene (Singh et al ., 1986, 1988 ; Hannik and
Donoghue, 1985 ; Yew et al., 1991) . We compared the rela-
tive in vitro autophosphorylation activity of the mos product
immunoprecipitated from equal volumes of CSF extracts
prepared from either unfertilized eggs or asynchronously
growing c-mosxe-transformed NIH/3T3 cells . Despite the
40-fold excess of pp39m° , in the c-mosxe-transformed cell
immune complex (Fig . 5 A), we observed that pp39m°, auto-
phosphorylation activity in this complex was significantly
lower than the activity displayed from an equal volume of
Xenopus egg extract (Fig . 5 B) . (The phosphorylated pro-
teins observed in the 55-58-kD range are cx- and ß-tubulin
that complex with and are substrates of pp39m°, in vitro and
perhaps in vivo [Zhou et al ., 1991x, b]) . Moreover, pp39m°5
autophosphorylation in immune complexes prepared from
mitotic c-mosxe-transformed cells was only two- to five-fold
higher than from asynchronous transformed cell populations
(data not shown) . This is consistent with the increase in auto-
kinase activity during M-phase recently reported for NIH/
3T3 cells transformed by v-mos (Liu et al ., 1990) . We con-
clude that the specific CSF or kinase activity of the Xenopus
mos product produced in transformed mouse cells is only a
fraction of the activity found in Xenopus eggs .
Discussion
In Xenopus, the mos proto-oncogene product is required for
MPF activation prior to GVBD and is a component of CSF,
an activity responsible for the stabilization ofMPF at meta-
phase II (Sagata et al ., 1988, 1989b ; Watanabe et al ., 1989) .
Metabolic labeling of oocytes shows that the mos product
is present throughout maturation (Sagata et al ., 1988 ;
Watanabe et al ., 1989) . We have shown that the mos prod-
uct is necessary during Xenopus oocyte maturation before
and after GVBD. We tested for pp39m° , function during
meiosis using two approaches . The injection of crude MPF
extracts into oocytes depleted ofmos RNA allowed oocytes
to advance through GVBD, albeit at a significantly slower
rate than in the presence of endogenous pp39m°, . It is curi-
ous that MPF-injected oocytes treated with cycloheximide
undergo GVBD within minutes of those competent for pro-
333tein synthesis (Gerhart et al., 1984), while GVBD in mos-
depleted oocytes takes 1 h longer. This could be explained
by a requirement for de novo synthesis of an inhibitor of
MPF during meiosis I, such as p40MO's, recently identified
by Shuttleworth et al . (1990). Most importantly, pp39mo,
synthesis was required after GVBD for the reappearance of
MPF activity later in maturation. It has previously been
shown that after GVBD, protein synthesis is required for
completion of meiosis I and the reappearance of MPF that
accompanies meiosis II (Gerhart et al., 1984) . Thus far, the
proteins that must be synthesized during this period have not
been identified; for example, cyclin synthesis is not required
for the first and second meiosis (Minshull, J., personal com-
munication). Our experiments show that mos protein is re-
quired after GVBD in Xenopus oocytes as well as before
GVBD (Sagata et al., 1988), and perhaps throughout meio-
sis since our experiments indicate that MPF and histone H1
kinase activities decrease precipitously in the presence of
mos antisense oligonucleotides. We have also shown that the
pp39mo, synthesized before GVBD does not eliminate the
requirement for mos product synthesis after GVBD and is
similar to results reported for mouse oocytes (Paules et al .,
1989; O'Keefe et al., 1989) . Our results as well as previous
reports indicate that, directly or indirectly, CSF stabilizes
MPF (Masui and Clarke, 1979 ; Newport and Kirschner,
1984; Murray et al., 1989; Sagata et al., 1989b). Our ex-
periments, however, do not distinguish between whether mos
product is required for the formation of an active MPF,
whether the MPF is unstable in the absence of mos product,
or both.
Constitutive expression of the mos proto-oncogene prod-
uct in somatic cells results in transformation (Oskarsson et
al., 1980; Blair et al ., 1981). We have postulated that expres-
sion of mos metaphase activity during interphase is responsi-
ble for the transformed phenotype. It has also been suggested
that the transformed phenotype may be due to CSF stabiliz-
ing MPF during interphase. In this report, we demonstrated
that CSF activity is present in c-more-transformed cells.
However, we were unable to detect MPF or its associated
histone H1 kinase activity in extracts prepared from an asyn-
chronous population of the c-mos,°-transformed cells, while
these activities were detected in mitotic cells. We conclude
that the ratio of CSF to MPF in unfertilized eggs is not main-
tained in c-mos,°-transformed cells, and the maintenance of
significant levels of MPF in these cells is apparently not a
component ofthe transformed phenotype. This is the first ex-
ample of a biological system showing that CSF activity can
exist during interphase and, more importantly, that this ac-
tivity can persist during interphase and not sustain detect-
able levels of MPF. It is possible that mouse tissue culture
cells may lack factors necessary for responding to CSF and
that other products may perform a similar function during
mitosis. We believe that the lack of mitotic arrest in mouse
cells transformed by the Xenopus mos product is not due to
species differences since the mouse mos product arrests em-
bryonic cleavage as efficiently as the Xenopus mos product
(Yew et al., 1991). In addition, mouse cells can be efficiently
transformed by the mouse mos product (Blair et al., 1981;
Yew et al., 1991). However, a question is raised regarding
the major function ofCSF. CSF may stabilize MPF, but only
during M-phase, indicating that MPF stability is a function
of more than one factor and that CSF stabilization of MPF
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is not direct and may require the synthesis of other proteins.
Consistent with this notion, extracts from c-mos,°-trans-
formed cells which contain active pp39m°, do not induce
GVBD in the absence of protein synthesis (data not shown) .
However, this result could be due to the levelofmos product
since more mos protein may be required to induce oocyte
maturation than embryonic arrest (Sagata et al ., 1989x,
Yew et al., 1991) .
The amount ofCSF activity per unit volume of cell extract
was very similar in extracts prepared from either eggs or
c-mos-transformed cells. At a 1:1 dilution, Xenopus egg ex-
tract induced embryonic arrest in approximately three-fold
more embryos than that of c-mos,° cell extract and roughly
correlates with the five-fold difference in autophosphoryla-
tion activity of mos product observed in these extracts. Sur-
prisingly, there was a 40-fold excess of mos product present
in the extract from c-mos,°-transformed cells. However,
mos protein autophosphorylation is only slightly higher in
immune complexes prepared from c-mos-transformed cells
held in mitosis by nocodozole. Collectively, these results in-
dicate that the mos product from transformed cells exhibits
only -2 % of the activity found in the product from egg
cytosol. CSF extracts diluted into extracts prepared from ei-
ther NIH/3T3 cells or fully grown Xenopus oocytes showed
no enhancement of CSF activity, indicating that there were
no limiting amounts of enhancing factor(s) . Posttranslational
modification such as phosphorylation could explain the
differences in CSF and c-mos,° autokinase activity. Another
possible explanation however, is that the amphibian mos
product is less stable in mouse cells at 37°C. It is also possi-
ble that a nondissociating negative regulatory factor like
tubulin oligomers (Zhou et al., 1991) associates with the mos
product in NIH/3T3 cells, since mixtures of egg and trans-
formed cell extracts showed no reduction in CSF activity
(data not shown).
How does a gene product that arrests embryonic cell cleav-
age transform somatic cells? It has been observed that cells
acutely infected with the Moloney murine sarcoma virus
express high levels of mos product, subsequently round up,
and detach from the monolayer (Fischinger and Haapala,
1971 ; Papkoff et al ., 1982). These infected cells express 30-
to 100-fold higher levels of mos product than transformed
cell populations (Papkoff et al., 1982). The morphological
alteration of mos-infected cellsmay be similar to that of mi-
totic rounding and might be an effect of CSF activity. We
have proposed that the mos product may be responsible for
the modification of tubulin and that mos, directly or indi-
rectly, is an effector of the transformed phenotype (Zhou et
al., 1991x, b) . We have postulated that the transformed phe-
notype may represent expression of mitotic events during in-
terphase (Sagata etal ., 1988) and that selection for the trans-
formed phenotype is a selection for cells expressing levels
of pp39m°, sufficient for transformation but below the levels
required for CSF arrest (Sagata et al ., 1989b). The specific
activity of the Xenopus pp39m°, is much lower in transformed
mouse cells than in unfertilized eggs suggesting that in
mouse cellsCSF/mos function is attenuated. The mechanism
of this attenuation may be equivalent to a tumor suppressor
function.
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